Intraportal islet oxygenation

Journal of Diabetes Science and Technology

Volumn 8, Issue 3, 2014, Pages 575-580

  Suszynski, Thomas M ^a   Avgoustiniatos, Efstathios S ^a   Papas, Klearchos K ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Anoxia; Hypoxia; Intraportal transplant; Islet transplant; Oxygenation

Indexed keywords

BLOOD CLOTTING; CELL FUNCTION; CELL SIZE; CELL SURFACE; CELL SURVIVAL; CELL VOLUME; HUMAN; INTRAPORTAL ISLET OXYGENATION; OXYGEN CONSUMPTION; OXYGEN SUPPLY; OXYGEN TENSION; OXYGENATION; PANCREAS ISLET; REVIEW; ADVERSE EFFECTS; ANIMAL; BLOOD; CELL DEATH; CELL HYPOXIA; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; METABOLISM; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; TREATMENT OUTCOME;

OXYGEN;

ANIMALS; CELL DEATH; CELL HYPOXIA; CELL SIZE; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; OXYGEN; OXYGEN CONSUMPTION; TREATMENT OUTCOME;

EID: 84900794366     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814525827     Document Type: Review

References (37)

1. Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant. 2012;12:1576-1583.
2. Weir GC, Bonner-Weir S, Leahy JL. Islet mass and function in diabetes and transplantation. Diabetes. 1990;39:401-405. (Pubitemid 20111419)
3. Eriksson O, Eich T, Sundin A, et al. Positron emission tomography in clinical islet transplantation. Am J Transplant. 2009;9:2816-2824.
4. Emamaullee JA, Shapiro AM. Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant. 2007;16:1-8. (Pubitemid 46516652)
5. Lau J, Henriksnas J, Svensson J, Carlsson PO. Oxygenation of islets and its role in transplantation. Curr Opin Organ Transplant. 2009;14:688-693.
6. Sakata N, Chan NK, Ostrowski RP, et al. Hyperbaric oxygen therapy improves early posttransplant islet function. Pediatr Diabetes. 2010;11:471-478.
7. Sakai T, Li S, Kuroda Y, Tanioka Y, Fujino Y, Suzuki Y. Oxygenation of the portal vein by intraperitoneal administration of oxygenated perfluorochemical improves the engraftment and function of intraportally transplanted islets. Pancreas. 2011;40:403-409.
8. Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000;105:125-133.
9. Larsen JL, Bennett RG, Burkman T, et al. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. Transplantation. 2006;82:466-470. (Pubitemid 44290251)
10. Desai NM, Goss JA, Deng S, et al. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation. 2003;76:1623-1625. (Pubitemid 37549837)
11. Thomas F, Wu J, Contreras JL, et al. A tripartite anoikis-like mechanism causes early isolated islet apoptosis. Surgery. 2001;130:333-338. (Pubitemid 32721688)
12. Medarova Z, Moore A. MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol. 2009;5:444-452.
13. Borot S, Crowe LA, Parnaud G, et al. Quantification of islet loss and graft functionality during immune rejection by 3-tesla MRI in a rat model. Transplantation. 2013;96:438-444.
14. Lau J, Carlsson PO. Low revascularization of human islets when experimentally transplanted into the liver. Transplantation. 2009;87:322-325.
15. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes. 2001;50:489-495. (Pubitemid 32195212)
16. Olsson R, Olerud J, Pettersson U, Carlsson PO. Increased numbers of low-oxygenated pancreatic islets after intraportal islet transplantation. Diabetes. 2011;60:2350-2353.
17. Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes. 2002;51:1362-1366. (Pubitemid 34826600)
18. Bonner-Weir S. Morphological evidence for pancreatic polarity of beta-cell within islets of Langerhans. Diabetes. 1988;37:616-621.
19. Sekine N, Cirulli V, Regazzi R, et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. J Biol Chem. 1994;269:4895-4902.
20. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes. 1993;42:12-21. (Pubitemid 23013790)
21. Cantley J, Grey ST, Maxwell PH, Withers DJ. The hypoxia response pathway and beta-cell function. Diabetes Obes Metab. 2010;12(suppl 2):159-167.
22. Cantley J, Walters SN, Jung MH, et al. A preexistent hypoxic gene signature predicts impaired islet graft function and glucose homeostasis. Cell Transplant. 2013;22:2147-2159.
23. Padera RF, Colton CK. Time course of membrane microarchitecture-driven neovascularization. Biomaterials. 1996;17:277-284. (Pubitemid 26031381)
24. Carlsson PO, Palm F, Mattsson G. Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab. 2002;87:5418-5423. (Pubitemid 36034337)
25. Avgoustiniatos ES, Colton CK. Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue. Ann N Y Acad Sci. 1997;831:145-167. (Pubitemid 28045272)
26. Hussey AJ, Winardi M, Han XL, et al. Seeding of pancreatic islets into prevascularized tissue engineering chambers. Tissue Eng Part A. 2009;15:3823-3833.
27. Hussey AJ, Winardi M, Wilson J, et al. Pancreatic islet transplantation using vascularised chambers containing nerve growth factor ameliorates hyperglycaemia in diabetic mice. Cells Tissues Organs. 2010;191:382-393.
28. Forster NA, Penington AJ, Hardikar AA, et al. A prevascularized tissue engineering chamber supports growth and function of islets and progenitor cells in diabetic mice. Islets. 2011;3:271-283.
29. Pedraza E, Coronel MM, Fraker CA, Ricordi C, Stabler CL. Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc Natl Acad Sci U S A. 2012;109:4245-4250.
30. Ludwig B, Rotem A, Schmid J, et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci U S A. 2012;109:5022-5027.
31. Barkai U, Weir GC, Colton CK, et al. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant. 2013;22:1463-1476.
32. Neufeld T, Ludwig B, Barkai U, et al. The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLOS ONE. 2013;8:e70150.
33. Wu H, Avgoustiniatos ES, Swette L, Bonner-Weir S, Weir GC, Colton CK. In situ electrochemical oxygen generation with an immunoisolation device. Ann N Y Acad Sci. 1999;875:105-125. (Pubitemid 29349065)
34. Li X, Chen H, Epstein PN. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J Biol Chem. 2004;279:765-771. (Pubitemid 38044882)
35. MacGregor RR, Williams SJ, Tong PY, Kover K, Moore WV, Stehno-Bittel L. Small rat islets are superior to large islets in in vitro function and in transplantation outcomes. Am J Physiol Endocrinol Metab. 2006;290:E771-E779.
36. Lehmann R, Zuellig RA, Kugelmeier P, et al. Superiority of small islets in human islet transplantation. Diabetes. 2007;56:594-603. (Pubitemid 46348450)
37. Fujita Y, Takita M, Shimoda M, et al. Large human islets secrete less insulin per islet equivalent than smaller islets in vitro. Islets. 2011;3:1-5.